Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research
BUCHANAN JR. and WORDSWORTH S., (2018), PharmacoEconomics - Open
Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study.
Doble B. et al, (2018), Health Qual Life Outcomes, 16
Effect of a strategy of supraglottic airway device versus tracheal intubation during out-of-hospital cardiac arrest on functional outcome: the AIRWAYS-2 randomized clinical trial.
Benger J. et al, (2018), JAMA - Journal of the American Medical Association, 320, 779 - 791
Cost-effectiveness of healthcare interventions for rare cancers: evidence from a systematic literature review and meta-analysis
TSIACHRISTAS A. et al, (2018), Journal of Cancer Policy
Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions
Regier DA. et al, (2018), Value in Health
Using “Big Data” in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions
Wordsworth S. et al, (2018), Value in Health
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions
Phillips KA. et al, (2018), Value in Health
Towards incentivising integration: A typology of payments for integrated care
Stokes J. et al, (2018), Health Policy
Preference-based measures to obtain health state utility values for use in economic evaluations with child-based populations: a review and UK-based focus group assessment of patient and parent choices.
Wolstenholme JL. et al, (2018), Qual Life Res, 27, 1769 - 1780
Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
Reed SD. et al, (2018), Diabetes Obes Metab, 20, 1732 - 1739
The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.
Smit AK. et al, (2018), Contemp Clin Trials, 70, 106 - 116
Comparison of statistical approaches for analyzing incomplete longitudinal patient-reported outcome data in randomized controlled trials
Rombach I. et al, (2018), Patient Related Outcome Measures
Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA)
Rutten-van Molken M. et al, (2018), BMC Health Services Research
Alcohol Screening and Brief Intervention in Police Custody Suites: Pilot Cluster Randomised Controlled Trial (AcCePT)
Addison M. et al, (2018), Alcohol And Alcoholism
Core Items for a Standardized Resource Use Measure: Expert Delphi Consensus Survey.
Thorn JC. et al, (2018), Value Health, 21, 640 - 649
A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial.
Kitchener H. et al, (2018), J Med Screen, 25, 88 - 98